Also known as: AZD1222 ChAdOx1 nCoV-19 COVID-19 Vaccine AstraZeneca
SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is indicated for:
Population group: both men and women, only adults (18 years old or older)
SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.
For this indication, competent medicine agencies globally authorize below treatments (click for details):